JP2007277095A - アジスロマイシン含有可逆性熱ゲル化水性組成物 - Google Patents

アジスロマイシン含有可逆性熱ゲル化水性組成物 Download PDF

Info

Publication number
JP2007277095A
JP2007277095A JP2004196515A JP2004196515A JP2007277095A JP 2007277095 A JP2007277095 A JP 2007277095A JP 2004196515 A JP2004196515 A JP 2004196515A JP 2004196515 A JP2004196515 A JP 2004196515A JP 2007277095 A JP2007277095 A JP 2007277095A
Authority
JP
Japan
Prior art keywords
aqueous composition
azithromycin
present
reversible
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004196515A
Other languages
English (en)
Japanese (ja)
Inventor
Shuichi Suzuki
秀一 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakamoto Pharmaceutical Co Ltd
Original Assignee
Wakamoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharmaceutical Co Ltd filed Critical Wakamoto Pharmaceutical Co Ltd
Priority to JP2004196515A priority Critical patent/JP2007277095A/ja
Priority to PCT/JP2005/012328 priority patent/WO2006004086A1/fr
Publication of JP2007277095A publication Critical patent/JP2007277095A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
JP2004196515A 2004-07-02 2004-07-02 アジスロマイシン含有可逆性熱ゲル化水性組成物 Pending JP2007277095A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2004196515A JP2007277095A (ja) 2004-07-02 2004-07-02 アジスロマイシン含有可逆性熱ゲル化水性組成物
PCT/JP2005/012328 WO2006004086A1 (fr) 2004-07-02 2005-07-04 Composition à base d’eau contenant de l’azithromycine qui subit une gélification thermique réversible

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004196515A JP2007277095A (ja) 2004-07-02 2004-07-02 アジスロマイシン含有可逆性熱ゲル化水性組成物

Publications (1)

Publication Number Publication Date
JP2007277095A true JP2007277095A (ja) 2007-10-25

Family

ID=35782887

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004196515A Pending JP2007277095A (ja) 2004-07-02 2004-07-02 アジスロマイシン含有可逆性熱ゲル化水性組成物

Country Status (2)

Country Link
JP (1) JP2007277095A (fr)
WO (1) WO2006004086A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
CN111214437A (zh) * 2018-11-27 2020-06-02 武汉武药科技有限公司 一种阿奇霉素微乳凝胶剂及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU220864B1 (en) * 1993-04-16 2002-06-29 Wakamoto Pharma Co Ltd Reversible, thermally gelling water-base medicinal compositions
GB9914346D0 (en) * 1999-06-19 1999-08-18 Univ Manchester Antibiotic agents
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
JP3450805B2 (ja) * 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
JP4947977B2 (ja) * 2003-10-31 2012-06-06 わかもと製薬株式会社 可逆性熱ゲル化水性組成物

Also Published As

Publication number Publication date
WO2006004086A1 (fr) 2006-01-12

Similar Documents

Publication Publication Date Title
JP4947977B2 (ja) 可逆性熱ゲル化水性組成物
JP3933683B2 (ja) アジスロマイシン含有水性医薬組成物及びその調製方法
US7612115B2 (en) Aqueous pharmaceutical compositions
RU2108112C1 (ru) Водная лекарственная композиция, обладающая свойством обратимого терморегулируемого гелеобразования
KR100365914B1 (ko) 점도가감소된안약조성물
JP5340149B2 (ja) 水性組成物
JP2010037327A (ja) ブリンゾラミド水性組成物
KR100215739B1 (ko) 가역성열겔화 수용성 의약 조성물을 함유하는 동결건조 제제
JP5870459B2 (ja) 点眼用水性組成物
WO1999063968A1 (fr) Preparations aqueuses contenant des medicaments faiblement solubles
JP6185725B2 (ja) 水性医薬組成物
JP2001081048A (ja) 眼圧降下剤
JP4263456B2 (ja) ヒアルロン酸含有熱ゲル化製剤
JP2007277095A (ja) アジスロマイシン含有可逆性熱ゲル化水性組成物
JP2729859B2 (ja) 可逆性熱ゲル化水性医薬組成物
JP2003095924A (ja) 熱ゲル化人工涙液
JP5420877B2 (ja) 眼科用剤
JP4081521B2 (ja) シプロフロキサシン含有水性組成物ならびに関連する使用および製法
JP4263418B2 (ja) 熱ゲル化人工涙液
JP3002733B2 (ja) インドメタシン含有貼付剤
JP2006036660A (ja) 難溶性薬物含有水性懸濁熱ゲル製剤
JP2007176932A (ja) 粘膜適用液剤
JPWO2009139213A1 (ja) プロクロルペラジン含有外用医薬組成物